In a world filled with fitness trackers and health apps, many people still struggle with a fundamental question: what is actually driving their health. Calibre is stepping out of stealth to answer that question, introducing a new category it calls Causal Health Navigation, backed by $3.3 million in pre seed funding to reshape how individuals understand and manage their wellbeing.
Backed by Health and Tech Investors
The funding round was led by Amino Collective, with participation from Daybreak Ventures and Cocoa Ventures. The company also attracted a group of experienced founders and medical experts, including Timo Boldt and Maximilian Tayenthal.
This backing highlights growing interest in solutions that move beyond basic health tracking toward actionable, personalised insights.
A Shift from Guesswork to Understanding
Despite increasing life expectancy, many people spend a significant portion of their lives in poor health. While most recognise the importance of healthy habits, a large number still lack clarity on what their body truly needs.
Traditional health tools often provide data without context, leaving individuals to interpret results on their own. Calibre aims to eliminate this guesswork by identifying the root causes behind health outcomes rather than simply tracking symptoms or behaviours.
Introducing Causal Health Navigation
At the core of Calibre’s approach is its concept of Causal Health Navigation. The platform combines clinical expertise with advanced AI to analyse a wide range of factors, including medical history, daily habits, and environmental influences.
By integrating this information with targeted diagnostic testing, Calibre creates a comprehensive and evolving picture of an individual’s health. This enables the platform to deliver personalised recommendations that address both immediate concerns and long term risks.
Personalised Care at Scale
Historically, this level of personalised health insight has been available only through expensive private healthcare services. Calibre is making it more accessible through a subscription model starting at £69 per month.
Members receive tailored guidance designed to improve daily energy levels, support lifestyle changes, and reduce the risk of future illness. The platform is intended to act as a long term health partner, adapting as users’ needs and circumstances evolve.
Clinical Foundation and Regulatory Focus
All clinical care is currently delivered through a partnership with DocTap, a regulated provider. At the same time, Calibre has submitted its own application to the Care Quality Commission, reflecting its commitment to maintaining high clinical standards as it scales.
This combination of technology and medical oversight ensures that recommendations are both data driven and clinically grounded.
Built by Experienced Founders
Calibre was founded by Alexander Weber, who previously played a key role in scaling N26 into a major fintech player. He is joined by Ben Levy, an experienced engineer who has worked on scaling healthtech companies such as Elvie and Manual, and Reinhold Innerhofer, a medical doctor and sports scientist with experience working with elite athletes.
This combination of expertise across technology, healthcare, and consumer products underpins the company’s vision.
Redefining the Future of Health
Calibre’s launch reflects a broader shift in how people think about health, from treating illness to proactively optimising wellbeing. By focusing on the underlying causes of health outcomes, the company aims to help individuals take control of their lives with greater confidence and clarity.
With its platform now open for early access through a waitlist, Calibre is positioning itself to lead a new wave of proactive health solutions. By turning complex data into meaningful action, it is working to ensure that better health is not just measured, but truly understood and improved over time.